Hinz et al(8) reported that Foxp3 is expressed in pancreatic cancer cells, and that Foxp3-expressing cancer cells inhibited the proliferation of CD4+CD25− T cells, potentially contributing to the immune evasion of the tumor cells. Here, CD4 is linked to neoplasm.